BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 6589752)

  • 1. A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1983; 41():151-7. PubMed ID: 6589752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment of staphylococcal septicaemia and endocarditis in a Swedish hospital.
    Svanbom M
    Scand J Infect Dis Suppl; 1983; 41():161-72. PubMed ID: 6589754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of beta-lactam antibiotics in the treatment of septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1984; 42():110-6. PubMed ID: 6442009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    Lowy FD; Wexler MA; Steigbigel NH
    J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus bacteremia and endocarditis.
    Chang FY
    J Microbiol Immunol Infect; 2000 Jun; 33(2):63-8. PubMed ID: 10917874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of staphylococcal septicaemia in compromised hosts.
    Solberg CO; Digranes A; Kalager T
    Scand J Infect Dis Suppl; 1983; 41():177-86. PubMed ID: 6589756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vancomycin in the treatment paradigm.
    Stevens DL
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
    Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
    Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New agents for Staphylococcus aureus endocarditis.
    Drees M; Boucher H
    Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus.
    Rayner C; Munckhof WJ
    Intern Med J; 2005 Dec; 35 Suppl 2():S3-16. PubMed ID: 16271060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy and prevention of infectious endocarditis].
    Horstkotte D; Rosin H
    Schweiz Med Wochenschr; 1984 Nov; 114(45):1575-86. PubMed ID: 6515354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy.
    Murray HW; Wigley FM; Mann JJ; Arthur RR
    Arch Intern Med; 1976 Apr; 136(4):480-3. PubMed ID: 1267557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG; Basuino L; Chambers HF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R
    Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.